Mylan and Biocon launch first Trastuzumab Biosimilar, Ogivri, in Australia
Ogivri is the first trastuzumab biosimilar approved and launched in Australia and available on the Pharmaceutical Benefits Scheme…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.